Fluxergy, a diagnostic company based in Irvine, CA developing an all-in-one Platform, is aiming to be the first in the space to address the key barriers to adopting point-of-care (POC) testing. Access to POC testing can make a significant impact on the quality of care provided by clinicians, especially in decentralized and lower-resource healthcare settings that send diagnostic tests out for results. Over the past few decades, there have been enormous advances in POC testing, miniaturizing lab-based testing platforms into easy-to-use, rapid, sample-to-answer platforms with accurate test solutions. However, adoption of these POC platforms has been limited by current POC platforms being able to run only one type of testing; concerns about non-laboratory personnel accurately and reproducibly performing this testing; and, most importantly, their high instrument and test costs. The Fluxergy Platform overcomes these limitations by combining the test modalities (molecular, immunochemistry, clinical chemistry, and cytometry) required to perform the most common blood and infectious disease tests into a single card.